(Q65394678)
Statements
A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (English)
0 references
3 February 2016
0 references
14 February 2018
0 references
378
0 references
18 year
0 references
51 year
0 references